You are here

Article info

Article menu
Download PDFPDF
Inflammatory bowel disease
Original article
Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer

Authors

  • Laurent Beaugerie Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine F-75012; ERL 1057 INSERM/UMRS 7203; GRC-UPMC 03, UPMC Univ Paris 06 F-75012, Paris, France PubMed articlesGoogle scholar articles
  • Fabrice Carrat Department of Public Health, Hôpital Saint-Antoine, AP-HP, F-75012 and UMR-S 707, INSERM & UPMC Univ Paris 06 F-75012, Paris, France PubMed articlesGoogle scholar articles
  • Jean-Frédéric Colombel Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articlesGoogle scholar articles
  • Anne-Marie Bouvier Registre Bourguignon des Cancers Digestifs F-21079; Inserm U866; CHRU Dijon; Université de Bourgogne, Dijon, France PubMed articlesGoogle scholar articles
  • Harry Sokol Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine F-75012; ERL 1057 INSERM/UMRS 7203; GRC-UPMC 03, UPMC Univ Paris 06 F-75012, Paris, France PubMed articlesGoogle scholar articles
  • Abdenour Babouri Inserm U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Université Henri Poincaré 1, Vandoeuvre-lès-Nancy, Nancy, France PubMed articlesGoogle scholar articles
  • Franck Carbonnel Department of Gastroenterology, Assistance Publique-Hôpitaux de Paris (AP-HP), University hospitals Paris-Sud, Site de Bicêtre, Paris Sud University, Paris XI, Le Kremlin Bicêtre, Villejuif, France PubMed articlesGoogle scholar articles
  • David Laharie CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie—Univ. Bordeaux, Laboratoire de bactériologie, F-33000 Bordeaux, Pessac, France PubMed articlesGoogle scholar articles
  • Jean-Luc Faucheron Colorectal Unit, Department of Surgery, Grenoble University Hospital, CS 10217, 38043 Grenoble cedex, Grenoble, France PubMed articlesGoogle scholar articles
  • Tabassome Simon Clinical Pharmacology Unit, Unité de Recherche clinique de l'Est Parisien, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, F-75012; UPMC Univ Paris 06, Paris, France PubMed articlesGoogle scholar articles
  • Aimery de Gramont Department of Oncology, AP-HP, Hôpital Saint-Antoine F-75012, Paris, France PubMed articlesGoogle scholar articles
  • Laurent Peyrin-Biroulet Inserm U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Université Henri Poincaré 1, Vandoeuvre-lès-Nancy, Nancy, France PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Laurent Beaugerie, Service de Gastroentérologie et Nutrition, Hôpital Saint-Antoine 184 rue du faubourg Saint-Antoine, 75571 Paris, Cedex 12, France; laurent.beaugerie{at}sat.aphp.fr
View Full Text

Citation

Beaugerie L, Carrat F, Colombel J for the CESAME Study Group, et al
Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer
Gut 2014;63:1416-1423.

Publication history

  • Received July 29, 2013
  • Revised August 31, 2013
  • Accepted October 8, 2013
  • First published October 25, 2013.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions